Back to search

Article

Autologous atrial appendage micrografts transplanted during coronary artery bypass surgery: design of the AAMS2 randomized, double-blinded, and placebo-controlled trial

2024-05-30

Abstract excerpt

<title>Abstract</title> <p> <italic> <bold>Background</bold> </italic> <italic>—</italic> The AAMS open-label clinical study demonstrated safety and feasibility of epicardial transplantation of autologous right atrial appendage micrografts (AAMs) during coronary artery bypass grafting (CABG) surgery. Delivered in an extracellular matrix patch, the study also provided first indications of reduced ischemic sca...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a82e125e-f2c2-5c4d-97f0-f42f3d63425b
DOI
10.21203/rs.3.rs-4294009/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Autologous atrial appendage micrografts transplanted during coronary artery bypass surgery: design of the AAMS2 randomized, double-blinded, and placebo-controlled trialDOI 10.21203/rs.3.rs-4294009/v1
Autologous cardiac micrografts as support therapy to coronary artery bypass surgerySemantic proximity
Epicardial transplantation of autologous atrial appendage micrografts–evaluation of safety and feasibility in pigs after coronary artery occlusionSemantic proximity
Safety and therapeutic potential of allogeneic adipose-derived stem cell spray transplantation in ischemic cardiomyopathy: a phase I clinical trialSemantic proximity
Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.Semantic proximity
Past Trends and Future Directions of Cardiac Regenerative Medicine – A Systematic Analysis of Clinical Trial RegistriesSemantic proximity
Autologous stem cell transplantation for myocardial repair.Semantic proximity
Cardiac fibrosis inhibitor CTPR390 prevents structural and morphological changes in collagen and fibroblasts of engineered human connective tissueSemantic proximity
Local delivery of decorin via hyaluronic acid microrods improves cardiac performance and ventricular remodeling after myocardial infarction.Semantic proximity
Bone marrow mesenchymal stem cells transfer in patients with ST-segment elevation myocardial infarction: single-blind, multicentre, randomized controlled trialSemantic proximity
Geometry influences inflammatory host cell response and remodeling in tissue-engineered heart valves in-vivo.Semantic proximity
Human Engineered Heart Tissue Models for Pharmacological Studies-Inhibition of Small-Conductance Ca <sup>2+</sup> -activated K <sup>+</sup> (K <sub>Ca</sub> 2) channelSemantic proximity
Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial.Semantic proximity
Select a neighboring publication to make it the new centre.